Literature DB >> 19176615

Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Emma Poole1, Ian Groves, Andrew MacDonald, Yin Pang, Antonio Alcami, John Sinclair.   

Abstract

Human cytomegalovirus (HCMV) regulates NF-kappaB during infection by a variety of mechanisms. For example, the HCMV gene product, UL144, is known to activate NF-kappaB in a tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6)-dependent manner, causing the upregulation of the chemokine CCL22 (MDC). Viral UL144 is expressed from the UL/b' region of the HCMV genome at early times postinfection and is a TNFR1-like homologue. Despite this homology to the TNFR1 receptor superfamily, UL144 does not bind to members of the TNF ligand superfamily. We show here that the upregulation of NF-kappaB by UL144 is dependent upon cellular tripartite motif 23 (TRIM23) protein. We propose a mechanism by which UL144 activates NF-kappaB through a direct interaction with the cellular protein TRIM23 in a complex containing TRAF6. In contrast, TRIM23 is not involved in conventional double-stranded RNA signaling via NF-kappaB. Therefore, we present a novel role for TRIM23 that is specific to UL144-mediated activation of NF-kappaB during the course of virus infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176615      PMCID: PMC2663253          DOI: 10.1128/JVI.02072-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Herpes simplex virus infection and apoptosis.

Authors:  Margot L Goodkin; Elise R Morton; John A Blaho
Journal:  Int Rev Immunol       Date:  2004 Jan-Apr       Impact factor: 5.311

2.  Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus.

Authors:  Takashi Nakayama; Kunio Hieshima; Daisuke Nagakubo; Emiko Sato; Masahiro Nakayama; Keisei Kawa; Osamu Yoshie
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Reevaluation of human cytomegalovirus coding potential.

Authors:  Eain Murphy; Isidore Rigoutsos; Tetsuo Shibuya; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

4.  The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta.

Authors:  Emma Poole; Biao He; Robert A Lamb; Richard E Randall; Stephen Goodbourn
Journal:  Virology       Date:  2002-11-10       Impact factor: 3.616

5.  TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1.

Authors:  U Schultheiss; S Püschner; E Kremmer; T W Mak; H Engelmann; W Hammerschmidt; A Kieser
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 6.  A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.

Authors:  M N Prichard; M E Penfold; G M Duke; R R Spaete; G W Kemble
Journal:  Rev Med Virol       Date:  2001 May-Jun       Impact factor: 6.989

7.  Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.

Authors:  Tohru Ishitani; Giichi Takaesu; Jun Ninomiya-Tsuji; Hiroshi Shibuya; Richard B Gaynor; Kunihiro Matsumoto
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

8.  Functional profiling of a human cytomegalovirus genome.

Authors:  Walter Dunn; Cassie Chou; Hong Li; Rong Hai; David Patterson; Viktor Stolc; Hua Zhu; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

9.  NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection.

Authors:  Margot L Goodkin; Adrian T Ting; John A Blaho
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.

Authors:  J Baillie; D A Sahlender; J H Sinclair
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  43 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

2.  Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.

Authors:  Ileana M Cristea; Nathaniel J Moorman; Scott S Terhune; Christian D Cuevas; Erin S O'Keefe; Michael P Rout; Brian T Chait; Thomas Shenk
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

4.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

5.  The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression.

Authors:  Christina Montag; Jutta Annabella Wagner; Iris Gruska; Barbara Vetter; Lüder Wiebusch; Christian Hagemeier
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

6.  Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

Authors:  Caroline Jefferies; Claire Wynne; Rowan Higgs
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

7.  TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity.

Authors:  Pradeep D Uchil; Angelika Hinz; Steven Siegel; Anna Coenen-Stass; Thomas Pertel; Jeremy Luban; Walther Mothes
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 8.  TRIM Proteins and Their Roles in Antiviral Host Defenses.

Authors:  Michiel van Gent; Konstantin M J Sparrer; Michaela U Gack
Journal:  Annu Rev Virol       Date:  2018-06-27       Impact factor: 10.431

Review 9.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

10.  Identifying targets of miR-143 using a SILAC-based proteomic approach.

Authors:  Yi Yang; Raghothama Chaerkady; Kumaran Kandasamy; Tai-Chung Huang; Lakshmi Dhevi N Selvan; Sutopa B Dwivedi; Oliver A Kent; Joshua T Mendell; Akhilesh Pandey
Journal:  Mol Biosyst       Date:  2010-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.